Search hospitals > Texas > Tyler
The University of Texas Health Science Center at Tyler
Claim this profileTyler, Texas 75708
Global Leader in Fibrosis
Global Leader in Cystic Fibrosis
Conducts research for Alpha-1 Antitrypsin Deficiency
Conducts research for Tuberculosis
Conducts research for Lung Disease
71 reported clinical trials
6 medical researchers
Summary
The University of Texas Health Science Center at Tyler is a medical facility located in Tyler, Texas. This center is recognized for care of Fibrosis, Cystic Fibrosis, Alpha-1 Antitrypsin Deficiency, Tuberculosis, Lung Disease and other specialties. The University of Texas Health Science Center at Tyler is involved with conducting 71 clinical trials across 69 conditions. There are 6 research doctors associated with this hospital, such as Pamela J McShane, MD, Julie V Philley, MD, Robert J. Volk, and Megan Devine, MD.Top PIs
Pamela J McShane, MDUniversity of Texas Health Science Center5 years of reported clinical research
Studies Tuberculosis
Studies Bronchiectasis
5 reported clinical trials
8 drugs studied
Julie V Philley, MDUniversity of Texas Health Science Center5 years of reported clinical research
Studies Tuberculosis
Studies Nontuberculous Mycobacterial Infections
3 reported clinical trials
6 drugs studied
Robert J. VolkM D Anderson Cancer Center4 years of reported clinical research
Studies Lung Cancer
Studies Cancer
3 reported clinical trials
4 drugs studied
Megan Devine, MDUniversity of Texas Health Center at Tyler3 years of reported clinical research
Studies Alpha-1 Antitrypsin Deficiency
Studies Emphysema
3 reported clinical trials
5 drugs studied
Clinical Trials running at The University of Texas Health Science Center at Tyler
Mycobacterium Avium Complex Infection
Tuberculosis
Nontuberculous Mycobacterial Infections
Lung Cancer
Nontuberculous Mycobacterial Lung Disease
Smoking
Parenting
Motivational Interviewing
Child Abuse
Infections
Antibiotic Therapy
for Mycobacterium Avium Complex Infection
NTM therapy consists of a multi-drug macrolide based regimen for 18-24 months. Treated patients frequently experience debilitating side effects, and many patients delay the start of antibiotic treatment due to these risks. Common side effects include nausea, diarrhea, and fatigue, and rare but serious toxicities include ocular toxicity, hearing loss, and hematologic toxicity. To date, most of the evidence underlying the current treatment recommendations has come from observational studies in which either a macrolide has been combined with rifampin and ethambutol, or in some cases combined with ethambutol alone. The proposed study will answer whether a third drug is necessary or whether taking two drugs can increase tolerability without a substantial loss of efficacy.
Recruiting1 award Phase 2 & 33 criteria
Clofazimine
for Mycobacterium Avium Complex Infection
The purpose of this study is to evaluate the clinical effectiveness and safety of clofazimine when used to treat Mycobacteria avium complex (MAC) lung disease. Funding Source - FDA OOPD
Recruiting0 awards Phase 2
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at The University of Texas Health Science Center at Tyler?
The University of Texas Health Science Center at Tyler is a medical facility located in Tyler, Texas. This center is recognized for care of Fibrosis, Cystic Fibrosis, Alpha-1 Antitrypsin Deficiency, Tuberculosis, Lung Disease and other specialties. The University of Texas Health Science Center at Tyler is involved with conducting 71 clinical trials across 69 conditions. There are 6 research doctors associated with this hospital, such as Pamela J McShane, MD, Julie V Philley, MD, Robert J. Volk, and Megan Devine, MD.